Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study. (Q40749248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author

Armelle Prévost-Blondel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Victor H Engelhard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Frédérique-Anne Le Gal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Renée Lengagne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Marc Bossus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Françoise Farace

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Aude Chaboissier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Hélène Gras-Masse

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Jean-Gérard Guillet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Hanne Gahéry-Ségard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

221-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857412%20AND%20SRC:MED&resulttype=core&format=json

T-cell recognition of melanoma-associated antigens

7 December 2019

cites work

1 reference

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

21 January 2018

1 reference

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

21 January 2018

1 reference

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

21 January 2018

1 reference

Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen

21 January 2018

1 reference

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

21 January 2018

1 reference

Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides

21 January 2018

1 reference

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

21 January 2018

1 reference

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

21 January 2018

1 reference

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

21 January 2018

1 reference

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

21 January 2018

1 reference

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

21 January 2018

1 reference

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells

21 January 2018

1 reference

Targeting p53 as a general tumor antigen

21 January 2018

1 reference

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses

21 January 2018

1 reference

Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation

21 January 2018

1 reference

Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.

21 January 2018

1 reference

Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1.

21 January 2018

1 reference

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

21 January 2018

1 reference

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

21 January 2018

1 reference

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro

21 January 2018

1 reference

21 January 2018

Solid phase synthesis

1 reference

IFN-gamma-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis

21 January 2018

1 reference